x

Search for a clinical trial

* (*) mandatory field

34 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

GERMANY

Baden-Württemberg
HEIDELBERG

An open-label, multicentre controlled clinical trial of Eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

GERMANY

Baden-Württemberg
HEIDELBERG

An open-label, multicentre controlled clinical trial of Eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

GERMANY

Baden-Württemberg
HEIDELBERG

An open-label, multicentre clinical trial of Eculizumab in pediatric patients with Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE- Completed
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

ITALY

LOMBARDIA
MILANO

Recruiting trial
Ongoing trial
An open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - IT
Ospedale Maggiore Policlinico - Clinica Pediatrica De Marchi
Centro per la Cura e lo Studio della Sindrome Emolitico Uremica (Center for HUS Control)

NETHERLANDS

Gelderland
NIJMEGEN

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
An open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - UK
University College London Hospitals, NHS Foundation Trust
Renal Office - Consultant Paediatric Nephrologist

Multinational clinical trial(s)